跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
iPSCs derived cell therapy
首页
药物
iPSCs derived cell therapy
iPSCs derived cell therapy
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
ALLOGENEIC CAR-T PLATFORM USING HLA-MATCHED BANK OF IPSCS, AND RELATED COMPOSITIONS, SYSTEMS, AND METHODS
申请人: SAPPHIROS AL BIO LLC
优先权: 2025
US
CORTICAL NEURAL PROGENITOR CELLS FROM IPSCS
申请人: CEDARS SINAI MEDICAL CENTER
优先权: 2019
CN
EP
US
WO
4 件公开
PLURIPOTENT STEM CELL-DERIVED RPE CELL, FORMULATION, PHARMACEUTICAL COMPOSITION, REAGENT, METHOD, AND KIT
申请人: HELP REGENERATIVE MEDICINE TECH SHENZHEN CO LTD
优先权: 2023
CN
EP
2 件公开
iPSC-derived cell compositions, and related systems and methods for cartilage repair
申请人: ORIG3N INC
优先权: 2018
CN
IPSC-DERIVED SECRETOME COMPOSITIONS, AND RELATED SYSTEMS AND METHODS
申请人: ORIG3N INC
优先权: 2017
US
WO
2 件公开
Compositions and methods for preclinical assessment using individualized genomic assembly and induced pluripotent stem cell lines of non-human primates
申请人: AXIR INC
优先权: 2021
CN
Mesenchymal stem cells of nasal mucosa and application
申请人: UNIV JIANGNAN
优先权: 2023
CN
药物
反馈